In a nutshell This article examined the evidence and made recommendations about weight loss in obese patients with type 2 diabetes (T2D). Some background Obesity is a common condition in people with T2D. Managing obesity in these patients can delay pre-diabetes advancing to T2D. Obesity management can also be helpful in treating T2D. Lifestyle...
Read MoreDiabetes mellitus Posts on Medivizor
The effects of dulaglutide in patients with type 2 diabetes
In a nutshell This article examined dulaglutide (Trulicity) in patients with type 2 diabetes (T2D). It found that dulaglutide was effective and tolerable. Some background T2D is a progressive disease. T2D may be controlled at first by lifestyle changes, like diet and exercise. However, eventually at least one, and often more, drugs may be...
Read MoreEffects of salt on the complications of type 2 diabetes
In a nutshell This study examined the link between salt (sodium) intake and complications of type 2 diabetes (T2D). The study found that high salt intake increased the risk of heart disease. Some background Heart disease, kidney disease, and vision problems are complications of T2D. It is recommended that patients with T2D decrease their...
Read MoreSafety of glucagon-like peptide 1 receptor agonists in type 2 diabetes
In a nutshell This study examined the connection between glucagon-like peptide 1 receptor agonists (GLP-1 RA) and pancreatitis, pancreatic cancer, and gallstones in patients with type 2 diabetes (T2D). It was found that GLP-1 RAs did not increase the risk of pancreatitis or pancreatic cancer, but did increase the risk of gallstones. Some...
Read MoreSearching for patients with type 1 diabetes to test new diet
In a nutshell This clinical trial will assess the impact of a new diet on the health of people with type 1 diabetes (T1D). The trial will take place in Sydney, Australia. The main outcome to be measured in change in HbA1c (average blood glucose over 3 months). The details T1D is an autoimmune disorder. This means that the body’s own immune...
Read MoreAre vildaglipton and insulin used together better for treating type 2 diabetes?
In a nutshell This study examined whether vildagliptin (Galvus) added to insulin treatment was safe and effective over the long term. The study concluded that vildagliptin in addition to insulin was effective and well tolerated by type 2 diabetes patients. Some background Patients with type 2 diabetes...
Read MoreGlucagon-like peptide 1 receptor agonists investigated in people with type 2 diabetes
In a nutshell This article compared the effects of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to insulin in patients with type 2 diabetes (T2D). The study concluded that weekly GLP-1 RAs were more effective in controlling blood glucose, and that all GLP-1 RAs reduced weight, compared to insulin. Some background T2D is a progressive...
Read MorePhysical activity reduces cardiovascular risk in people with type 1 diabetes
In a nutshell This study investigated the relationship between physical activity and cardiovascular disease (CVD) in patients with type 1 diabetes (T1D). It was found that physical activity decreases the risk of CVD in these patients. Some background CVD is the most common cause of premature death and disability in people with T1D. Physical...
Read MoreMediterranean diet and sexual function in people with type 2 diabetes
In a nutshell This study compared the effects of a Mediterranean diet with a low-fat diet on sexual function in patients with type 2 diabetes (T2D). It was found that the Mediterranean diet reduced loss of sexual function. Some background T2D has been linked to a decline in sexual function, in both men and women. Previous research has found...
Read MoreGemigliptin effective as part of combination drug therapy in type 2 diabetes
In a nutshell This study examined the impact of gemigliptin as part of a combination with metformin (Glucophage) and glimepiride (Amaryl) in patients with type 2 diabetes (T2D). The study found that gemigliptin was effective in the management of T2D in combination with metformin and glimepiride. Some background...
Read MoreComparing high blood pressure treatment options for patients with diabetes
In a nutshell This study compared the effects of different treatments for high blood pressure (hypertension) in patients with diabetes. The authors concluded that patients with type 2 diabetes benefited from hypertensive treatment if they had high systolic blood pressure (above 140 mm Hg). No significant differences were observed between different...
Read MoreHypoglycemia increases the risk of cardiovascular events in patients with type 2 diabetes
In a nutshell This study examined the risk of serious cardiovascular events, such as heart attack and stroke, in patients with type 2 diabetes (T2D). It found that hypoglycemia (low blood-glucose) was associated with an increased risk of these events. Some background Patients with T2D are at a higher risk of cardiovascular events. Previous studies...
Read More
